SEOUL, South Korea – October 17, 2025 – MediumBank (Shanghai MediumBank Biotechnology Co., Ltd.), a leading provider of cell culture media and bioprocess solutions, successfully participated in BioPlus-Interphex Korea (BIK) 2025. The exhibition was held from October 15 to 17 at the COEX Hall C & Conference Room in Seoul, South Korea. The MediumBank team engaged with numerous visitors and partners at Booth #F16.
As a premier industry platform covering the entire biopharmaceutical value chain, BIK facilitated significant networking and showcased the latest technological advancements. During the event, MediumBank highlighted its latest innovations designed to accelerate upstream bioprocess development. The booth attracted notable attention with demonstrations of its:
Next-Generation CHO Cell Serum-Free Media Platform: Designed to enhance cell growth, productivity, and product quality consistency.
High-Efficiency Transient Transfection Solutions: Streamlined systems supporting rapid and scalable protein expression for research and development.
Mr. Wang Yantao, Founder, Chairman, and CEO of MediumBank, attended the exhibition and held in-depth discussions with key clients and industry partners. These exchanges focused on collaborative opportunities and the growing global demand for reliable, high-performance upstream materials.
The successful participation in BIK 2025 reinforced MediumBank's commitment to supporting the global biomanufacturing community with innovative and scalable solutions. The company looks forward to further strengthening partnerships and contributing to the advancement of the biopharmaceutical industry worldwide.
